Policy & Regulation
Ethris forms strategic collaboration with Thermo Fisher Scientific to expand access to mRNA platforms
13 June 2025 - Ethris GmbH, a clinical-stage biotechnology company developing next-generation RNA therapeutics and vaccines, on Friday announced a strategic collaboration with life science and clinica...
FDA approves Merck's KEYTRUDA for perioperative use in PD-L1+ head and neck cancer
13 June 2025 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Friday that the US Food and Drug Administration has approved KEYTRUDA (pemb...
Alligator Bioscience gains FDA support for Phase 3 mitazalimab dose in pancreatic cancer
13 June 2025 - Swedish biotechnology company Alligator Bioscience AB (STO:ATORX) announced on Friday that the US Food and Drug Administration (FDA) has endorsed the 900 µg/kg dose of mitazalimab...
Sumitomo Pharma America's nuvisertib (TP-3654) receives US FDA Fast Track Designation for myelofibrosis treatment
13 June 2025 - Sumitomo Pharma America Inc (SMPA), a US subsidiary of Japan's Sumitomo Pharma Co Ltd (TYO:4506), announced on Thursday that the US Food and Drug Administration (FDA) has granted F...
Life Molecular Imaging's florbetaben (18F) granted orphan designation in Europe for Transthyretin (ATTR) Amyloidosis diagnosis
13 June 2025 - Germany-based Life Molecular Imaging GmbH (LMI) announced on Thursday that florbetaben (18F) has been granted orphan designation by the European Commission for the diagnosis of Transthy...
Specialised Therapeutics and Incyte include two additional therapies in expanded partnership
13 June 2025 - Australian biopharmaceutical company Specialised Therapeutics (ST) announced on Thursday the expansion of its existing supply and distribution agreement with Incyte Biosciences Internat...